The lung, which facilitates oxygen exchange and defends against inhaled toxicants, is frequently exposed to infectious or noxious injury. Injured lungs can undergo facultative regeneration to restore alveolar architecture and cellular components [1] [2] [3] [4] [5] [6] [7] [8] . During lung repair, fibroblasts produce matrix to facilitate this process. However, uncontrolled matrix production by fibroblasts results in exuberant scar formation and fibrosis [9] [10] [11] [12] [13] [14] , perturbing pulmonary function. Thus, understanding the mechanisms that modulate fibroblast function in lung repair is crucial for designing strategies to promote lung regeneration and inhibit fibrosis.
Vascular endothelial cells regulate lung function in ways that extend beyond their role in delivering oxygen [15] [16] [17] [18] . Specialized PCECs produce paracrine factors to stimulate the propagation of alveolar progenitor cells 15, 19 . The majority of alveolar fibroblasts are localized in the vicinity of PCECs, implicating a possible contribution of PCECs in regulating the properties of perivascular fibroblasts [20] [21] [22] . Nevertheless, the manner in which aberrantly activated PCECs might stimulate perivascular fibroblasts to evoke fibrosis remains to be studied 23 . To this end, cell type-specific gene engineering is needed to elucidate the interaction between PCECs and perivascular fibroblasts during lung repair.
The Notch pathway is pivotal in controlling the phenotype of lung cells, such as pulmonary artery and bronchial smooth muscle cells and fibroblasts 6, 7, 12, [24] [25] [26] , suggesting the possible contribution of this pathway in modulating perivascular fibroblasts. Moreover, Notch ligands are expressed by lung fibroblasts at low levels, suggesting non-cell-autonomous regulation of Notch in fibroblasts 27 . In contrast, endothelial cells express high amounts of Notch ligands with distinct functions, including Jagged1 (Jag1), Jagged2 (Jag2), and delta-like ligand 1 and 4 (Dll1 and Dll4) [28] [29] [30] [31] [32] [33] . As such, we hypothesized that PCECs express Notch ligands to modulate juxtacrine Notch signaling in perivascular fibroblasts, thereby orchestrating lung repair after injury. In this study, we reveal the contribution of PCEC-expressed Jag1 in regulating lung repair and fibrosis, as well as its modulation by macrophages in a pulmonary hematopoieticvascular niche.
RESULTS

Repeated lung injury inhibits repair and stimulates fibrosis
To test the influence of PCECs on lung repair and fibrosis, we used a repetitive intratracheal (i.t.) bleomycin-injection model 34 (Fig. 1a) . One to six doses of bleomycin were injected into the trachea of mice, and lung gas exchange function was monitored by measuring the blood oxygen level after each injection. After each of the first three injections of bleomycin, the blood oxygen level decreased but then recovered; however, this alveolar functional recovery no longer occurred after the fourth injection (Fig. 1b) . Because type 1 alveolar epithelial cells (AEC1s) are the main cell type that mediates lung gas exchange, we examined AEC1 distribution. Acute or chronic injury was induced by one or six injections of bleomycin, respectively. We assessed epithelial damage and re-epithelialization after injury by immunostaining of the AEC1 markers aquaporin-5 and podoplanin. AEC1 architecture was damaged by a single bleomycin injection and subsequently restored in a time-dependent manner ( Fig. 1c and Supplementary Fig. 1a ). In contrast, this re-epithelialization was inhibited after six bleomycin injections, leading to a sustained disruption of alveolar epithelial morphology. Moreover, proliferation of surfactant protein C-positive (SFTPC) + type 2 alveolar epithelial cells (AEC2s) occurred after initial bleomycin injections, but this response no longer occurred after the fifth injection ( Supplementary Fig. 1b,c) . Therefore, restoration of epithelial structure and of gas exchange function in injured alveoli are impeded by repetitive (chronic) lung injury.
In parallel, we examined fibrotic responses after each injection of bleomycin, as assessed by the protein levels of α-smooth muscle actin (SMA) and collagen I (Fig. 1d,e) . SMA and collagen I protein levels were reduced at day 35 after one or two bleomycin injections, but this timedependent resolution of fibrosis no longer occurred after the fourth injection (Supplementary Fig. 1d ). Multiple bleomycin injections caused substantially higher levels of fibrosis than did a single bleomycin injection, as assessed by hydroxyproline levels, Sirius red staining to detect collagen I deposition, and H&E staining (Fig. 1f,g and Supplementary Fig. 1e-h ). Thus, repetitive bleomycin injection causes sustained fibrosis in the injured lungs.
Notch signaling modulates the phenotype of lung fibroblasts 26, 27 . We therefore used transgenic Notch reporter (TNR) mice, in which GFP expression is driven by the Notch effector RBP-J, to examine Notch activation in the injured lungs ( Fig. 1h and Supplementary  Fig. 2 ). Notch activation (GFP expression) was preferentially induced in perivascular fibroblasts positive for the fibroblast marker desmin after six bleomycin injections. On the basis of this result, we postulated that exuberant Notch signaling in perivascular fibroblasts might contribute to impaired lung repair and fibrosis after chronic injury.
Jagged1 in aberrantly activated PCECs stimulates lung fibrosis
To study the mechanism whereby Notch is activated in perivascular fibroblasts after bleomycin injury, we examined the expression pattern of Notch ligands in injured mouse lungs. Among the tested Notch ligands, we found that Jag1 expression in PCECs was upregulated by the fourth bleomycin injection, which was the time point at which sustained Figure 1 Repetitive lung injury causes sustained alveolar epithelial cell damage, irreversible pulmonary fibrosis, and persistent Notch signaling in perivascular fibroblasts. (a) The experimental scheme for inducing chronic lung injury in mice using repeated i.t. injections of bleomycin (Bleo).
(b) Blood oxygen levels in mice after bleomycin treatment. Each dot represents data from one animal; n = 10 animals in the PBS-treated groups and the '1 Bleo' and '2 Bleo' groups, and n = 9 mice for the other groups; *P < 0.05. One-way analysis of variance (ANOVA) was used to compare groups throughout the study. npg fibrosis became evident ( Fig. 2a and Supplementary Fig. 3a-c) .
Analysis of immunostained lung sections obtained from individuals with interstitial pulmonary fibrosis also suggested upregulation of Jag1 preferentially in PCECs, as compared to Jag1 expression in normal human lungs (Supplementary Fig. 3d ). Hence, we hypothesized that aberrantly activated PCECs produce Jag1 to instigate Notch signaling in perivascular fibroblasts, thereby promoting fibrosis.
To test this hypothesis, we used an endothelial cell-specific inducible gene deletion strategy. VE-cadherin-Cre ERT2 mice, in which a tamoxifen-responsive Cre is expressed under the control of the endothelial cell-specific VE-cadherin promoter, were crossed with mice harboring floxed Jag1 (Fig. 2b) . Treatment of the resulting mice (VE-cadherin-Cre ERT2 Jag1 loxP/loxP , referred to as Jag1 i∆EC/i∆EC ) with tamoxifen selectively ablated Jag1 in endothelial cells of adult mice. Mice with haplodeficiency of Jag1 (VE-cadherin-Cre ERT2 Jag1 loxP/+ , referred to as Jag1 i∆EC/+ ) were used as the control group. After repeated bleomycin injections, the extent of the fibrotic response in the lungs of Jag1 i∆EC/i∆EC mice was markedly lower than in control mice, as assessed by SMA and collagen I protein levels and hydroxyproline content ( Fig. 2c-e and Supplementary Fig. 3e,f) . These results indicate that chronic bleomycin injury upregulates Jag1 expression in PCECs to enhance fibrosis.
To monitor Notch activation, we also generated TNR + Jag1 i∆EC/i∆EC mice. Compared to TNR + Jag1 i∆EC/+ mice, Notch activation (GFP signal) was reduced in platelet-derived growth factor receptor beta-positive (PDGFR-β + ) fibroblasts of TNR + Jag1 i∆EC/i∆EC mice (Supplementary Fig. 3g ). We then investigated the PCEC-lung fibroblast interaction in a co-culture system. Primary mouse PCECs were incubated with lung fibroblasts on Matrigel ( Supplementary  Fig. 4a ). Among the tested Notch downstream effectors, Hes1 was the most activated in the co-cultured fibroblasts ( Supplementary  Fig. 4b) , and both Hes1 expression and activation of the co-cultured Supplementary Figure 3b- Fig. 4c-e) . Notably, we also observed a time-dependent activation of Hes1 in lung fibroblasts of bleomycin-injured mice ( Supplementary Fig. 4f,g ). In addition, Notch signaling in co-cultured lung fibroblasts was associated with activation of Smad3, a critical component of the TGF-β pathway 35 . (Supplementary Fig. 5 ). This result led us to examine Smad activation in lung fibroblasts after bleomycin injury. As assessed by electrophoretic mobility shift assay (EMSA), Smad3 activity in injured lung fibroblasts was attenuated in Jag1 i∆EC/i∆EC mice, as compared to control mice (Fig. 2f) . Thus, Jag1 upregulation in PCECs induces Notch signaling in lung fibroblasts, which might result in fibrosis.
Effect of vascular-targeted Jag1 shRNA on lung fibrosis The pro-fibrotic function of PCEC Jag1 in chronic lung injury suggests that targeting Jag1 in PCECs could prevent fibrosis. The large surface area of PCECs that is accessible to the blood circulation can be targeted by agents conjugated with antibodies that recognize endothelial cell antigens 36 . We therefore generated an endothelial cell-specific gene transduction system, using a pseudotyped lentivirus 37 ( Supplementary Fig. 6a ). This packaging system incorporates an immunoglobulin G (IgG)-recognizing motif in viral surface proteins, facilitating conjugation with IgG molecules. To achieve endothelial cell-specific targeting of Jag1, the rat monoclonal antibody (mAb) Mec13.3, which recognizes the endothelial cell-enriched antigen CD31, was conjugated with pseudotyped lentivirus encoding Jag1 shRNA (shJag1 EC virus), a scrambled sequence control (Srb EC virus) or Gfp (Gfp EC virus). The in vivo effects of the conjugated lentiviruses were tested after jugular vein injection. Injection of Gfp EC virus resulted in GFP expression in VE-cadherin + PCECs but not E-cadherin + AECs ( Fig. 2g and Supplementary  Fig. 6b,c) . Injection of shJag1 EC virus after the fourth bleomycin injection, and every 6 d thereafter, blocked Jag1 upregulation in PCECs and attenuated pulmonary SMA protein levels, as compared to injection of control Srb EC virus (Fig. 2h) . Moreover, these effects were associated with reduced levels of hydroxyproline, collagen I, and fibroblast Hes1 in the injured lungs (Fig. 2i,j and Supplementary  Fig. 6c-h ). Thus, targeting of induced Jag1 in PCECs during chronic lung injury could potentially abrogate fibrosis.
Contribution of CXCR7 to lung repair after bleomycin injury Next, we sought to define the molecular mechanisms involved in the upregulation of Jag1 in PCECs. Induction of expression of the chemokine receptor CXCR7, which is expressed predominantly in endothelial cells, promotes liver repair and limits atherosclerosis 23, 38 . Thus, we examined CXCR7 expression in PCECs. CXCR7 expression in PCECs was attenuated in repeatedly bleomycin-injected mice and in individuals with pulmonary fibrosis (Fig. 3a,b and Supplementary  Fig. 7a,b) , implicating a protective function of PCEC CXCR7. Compared to a low level of CXCR7 expression level in liver endothelial cells, CXCR7 protein was highly expressed by PCECs ( Supplementary  Fig. 7c,d ). In parallel, we found that the CXCR7 ligand CXCL12 (also known as SDF-1) expression in the lungs of mice was upregulated by bleomycin injection (Supplementary Fig. 7e ). Thus, we tested the effect of the CXCR7 agonist TC14012 on fibrotic responses. Indeed, local (i.t.) infusion of the CXCR7 agonist TC14012 after the third bleomycin injection reduced collagen deposition and prevented alveolar epithelial damage ( 
Sirius red H&E Figure 3 The CXCL12 receptor CXCR7 promotes lung repair and suppresses fibrosis after bleomycin injury. npg deletion of Cxcr7 (Cxcr7 i∆EC/i∆EC ) and control mice with endothelial cell-specific Cxcr7 haplodeficiency (Cxcr7 i∆EC/+ ). Local instillation of TC14012 attenuated protein levels of Jag1, SMA and Hes1 in injured control but not Cxcr7 i∆EC/i∆EC mouse lungs (Fig. 3f-h and Supplementary Fig. 8a,b) . Moreover, injection of shJag1 EC virus reduced protein levels of SMA and collagen I in both wild-type (WT) and Cxcr7 i∆EC/i∆EC mice ( Fig. 3i and Supplementary Fig. 8c,d ). These data suggest that CXCR7 activation in PCECs protects against epithelial damage and prevents pro-fibrotic responses in PCECs, such as Jag1 upregulation (Supplementary Fig. 8e ).
CXCR7 inhibits -catenin-dependent Jag1 induction in injured PCECs
As the Wnt/β-catenin pathway can stimulate Notch ligand upregulation 39, 40 , we examined β-catenin pathway activation in bleomycin-injured mice using Axin2-lacZ reporter mice. We observed activation of β-catenin (β-galactosidase) in VE-cadherin + PCECs at day 10 after four injections of bleomycin ( Fig. 4a and Supplementary Fig. 9a) , which was the time point at which endothelial Jag1 expression was persistently upregulated. In cultured mouse PCECs, addition of Wnt3A increased Jag1 expression, and this effect was dampened by TC14012 in WT but not Cxcr7-deficient PCECs ( Fig. 4b and Supplementary Fig. 9b ). These data implicate the Wnt/β-catenin pathway activation in PCECs in perpetuating Jag1 expression. We next sought to discover the cellular mechanisms leading to β-catenin activation in PCECs after chronic injury. Macrophages and monocytes produce Wnt ligands to modulate the vascular phenotype 13, [41] [42] [43] [44] [45] [46] . Thus, we tested the contribution of macrophages to pathological β-catenin activation in injured lungs 47 . We generated an endothelial cell-specific β-catenin gain of function mouse line by crossing mice harboring a floxed Ctnnb1 (encoding β-catenin) exon 3 allele with VE-cadherin-Cre ERT2 mice, generating Ctnnb1-Ex3 i∆EC/+ mice (Fig. 4c) . The region of the β-catenin protein encoded by exon 3 mediates degradation of the protein; therefore, deletion of exon 3 generates a constitutively active form of β-catenin 48, 49 . We subjected control and Ctnnb1-Ex3 i∆EC/+ mice to clodronate liposome-mediated macrophage depletion before the fourth bleomycin injection. As assessed by PCEC Jag1 expression lung SMA levels, macrophage and monocyte depletion prevented fibrotic responses in control but not Ctnnb1-Ex3 i∆EC mouse lungs ( Fig. 4d and Supplementary  Fig. 9c,d) . In contrast, TC14012 attenuated Jag1 induction in both Fig. 9e,f) . Thus, after repeated lung injury, macrophages seem to mediate the overactivation of β-catenin in PCECs, leading to upregulation of pro-fibrotic Jag1.
VEGFR1 + macrophages modulate -catenin pathway activation in PCECs To unravel how macrophages mediate β-catenin activation in PCECs, we examined Wnt ligand production in F4/80 + CD11b + macrophages after repeated bleomycin injections. We observed preferential upregulation of Wnt3A in isolated macrophages (Fig. 4e) . In vivo, Wnt3A expression in F4/80 + CD11b + macrophages was specifically enhanced by injection of placental growth factor (Plgf), a ligand of VEGFR1 (refs. 50-54) (Fig. 4f) . Indeed, Plgf expression was upregulated in chronically injured lungs (Supplementary Fig. 10a ). Based on these findings, we examined the recruitment of VEGFR1 + cells to bleomycin-injured lungs using Vegfr1-lacZ reporter mice 52 . Repeated bleomycin injections led to a marked increase in the numbers of CD11b + F4/80 + VEGFR1 + macrophages ( Fig. 4g and Supplementary  Fig. 10b,c) . Moreover, deletion of Vegfr1 using LysM-Cre (Vegfr1 ∆LysM/ ∆LysM ) blocked expression of Wnt3A in F4/80 + CD11b + macrophages after bleomycin treatment ( Fig. 4h and Supplementary Fig. 10d-f ). Jag1 induction in PCECs was similarly abrogated in Vegfr1 ∆LysM/∆LysM mice ( Supplementary Fig. 10g,h ). These findings suggest that, after chronic lung injury, VEGFR1-expressing perivascular macrophages evoke pathological activation of the β-catenin pathway in PCECs.
To formally test the effect of VEGFR1 + macrophages on the β-catenin-Jag1 axis in PCECs, we used an adoptive monocyte transfer strategy 47 in WT and Ctnnb1-Ex3 i∆EC/+ mice (Fig. 5a) . Transplantation of Vegfr1 −/− monocytes (obtained from Vegfr1 ∆LysM/ ∆LysM mice) into WT mice caused a significantly lower extent of fibrosis after bleomycin injection, compared to mice receiving Vegfr1 +/+ monocytes (obtained from WT mice) (Fig. 5b-d) . In contrast, this differential effect of Vegfr1 −/− and Vegfr1 +/+ monocytes was lost in Ctnnb1-Ex3 i∆EC/+ mice. Notably, CXCR7 agonist TC14012 attenuated lung fibrosis in all of these groups (Fig. 5c,d) . Moreover, decreased lung fibrosis, in the setting of both Vegfr1 −/− monocyte infusion and TC14012 treatment, was associated with lower Jag1 expression (Fig. 5e,f) . These findings further implicate recruitment of VEGFR1-activated macrophages in stimulating a pro-fibrotic β-catenin-Jag1 axis in PCECs, which is tempered by CXCR7 signaling in PCECs (Supplementary Fig. 10i ).
Role of CXCR7 and Jag1 after repeated acid aspiration injury To examine whether the effects of CXCR7 and Jag1 in the bleomycin model can be generalized to another lung injury model, we used i.t. instillation of 0.1 M hydrochloric acid (Fig. 6a) . A single treatment with acid disrupted alveolar epithelial structure, which was followed by recovery of AEC1 numbers and restoration of lung respiratory capacity ( Supplementary Fig. 11a-c) . In contrast, repeated acid treatment blocked re-epithelialization and increased collagen I deposition in the injured lungs (Supplementary Fig. 11d,e) . Next, we used this acid injury model to test the therapeutic effects of the CXCR7 agonist TC14012 and of shJag1 EC virus. TC14012 infusion attenuated alveolar epithelial injury and reduced fibrotic responses after repetitive acid treatment (Fig. 6b-e and Supplementary Fig. 12a-d) . Similarly, injection of shJag1 EC virus maintained alveolar epithelial architecture, blocked lung fibrosis, and inhibited fibroblast Notch activation after the fifth round of acid aspiration (Fig. 6f-h and Supplementary Fig. 12e,f) . Moreover, shJag1 EC 
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+/+ virus injection preserved the gas exchange function of injured lungs (Fig. 6i) . Thus, endothelial cell-specific activation of CXCR7 or knockdown of Jag1 in chronically injured PCECs can stimulate functional lung repair and mitigate fibrosis.
DISCUSSION
Fibrosis is involved in the progression of various lung diseases, and it can have fatal consequences. Modulation of lung regeneration and fibrosis could have substantial value in treating lung disease [9] [10] [11] 34 . After surgical removal of the left lobe of the lung in rodents, the remaining lobes regrow without fibrosis, and, in many patients with acute lung injury, scar deposition in the lungs after injury resolves over time. By contrast, chronic insult to the lungs (for example, due to asbestos or silica deposition) can lead to exuberant scar formation, resulting in fibrosis that perturbs lung function. Here we show that iterative lung injury with bleomycin affects CXCR7 expression in mouse PCECs, leading to upregulation of pro-fibrotic Jag1. In parallel, Jag1 induction in PCECs is promoted via an interaction of PCECs with VEGFR1 + perivascular macrophages, leading to β-catenin activation in PCECs. We also showed that the effects of endothelial CXCR7 and Jag1 could be generalized to a second lung injury model, acid aspiration. Our findings indicate that after sustained lung injury, VEGFR1 + perivascular macrophages interact with PCECs to form a maladapted 'hematopoietic-vascular niche' , evoking fibrosis (Fig. 6j) . Spatial and temporal regulation of Notch signaling intricately balances lung regeneration and fibrosis after injury. For example, a recent study suggested that Notch signaling is essential for activation of lineage-negative epithelial stem/progenitor cells (LNEPs) in the lung after influenza infection 6 . In this setting, Notch-Hes1 signaling in LNEPs stimulates their proliferation and migration, but a subsequent decrease in Notch signaling in LNEPs is necessary for these lung progenitors to differentiate into alveolar epithelial cells. Aberrantly sustained Notch activity in injured lungs led to an alveolar cyst architecture that is indicative of a fibrotic phenotype 6 . Here we found that persistent upregulation of the Notch ligand Jag1 in chronically injured PCECs causes sustained Notch activation in perivascular fibroblasts. Notably, both Notch activation and fibrotic injury were attenuated in the lungs of Jag1 i∆EC/i∆EC mice, implicating endothelial Jag1 in the induction of pro-fibrotic Notch signaling in perivascular fibroblasts. How other Notch ligands expressed in different cell types modulate Notch activity in injured lungs remains to be clearly defined 31, 33 .
Suppression of the 'built-in' protective CXCR7 pathway in PCECs by repeated injury prevents alveolar repair and promotes fibrosis. , and blood oxygenation (i). *P < 0.05 by one-way ANOVA between shJag1 EC and Srb EC groups. Quantification of protein levels is shown in Supplementary Figure 12 . n = 9 animals per group. (j) The lung hematopoietic-vascular niche modulates alveolar repair and fibrosis. After acute injury, CXCR7 in PCECs promotes an epithelial response (AEC proliferation) and prevents fibrosis. After chronic injury, recruitment of VEGFR1 + perivascular macrophages instigates pathological Jag1 upregulation in PCECs, dependent on Wnt/β-catenin signaling. This sustained upregulation of Jag1 elicits juxtacrine Notch activation in perivascular fibroblasts, promoting pulmonary fibrosis. Targeting of this niche could enhance alveolar epithelial repair and ameliorate lung fibrosis. β-actin was used as a loading control in d,g.
npg
The anti-fibrotic role of CXCR7 is at least partially due to inhibition of β-catenin-dependent induction of Jag1 39, 40 . Future studies should investigate the role of CXCR7 in modulating the physiological function of the β-catenin pathway in endothelial cells of specific vascular beds 48, 49 , as well as the potential involvement of the CXCL12 receptor CXCR4 23, 55 . The anti-fibrotic function of CXCR7 in PCECs extends the previously discovered role of PCECs in enabling lung alveolar regeneration 15, 18 , and future study is also needed to identify CXCR7-triggered endothelial paracrine molecules 18 that evoke alveolar epithelial repair. Macrophages regulate vascular remodeling and patterning 13, [41] [42] [43] [44] . Here we showed that VEGFR1 + perivascular macrophages stimulate β-catenin-dependent Jag1 expression in PCECs. The contribution of VEGFR1 in macrophages and/or monocytes 44,53 was evidenced by the reduced level of lung injury in Vegfr1 ∆LysM/∆LysM mice and by the beneficial effects of adoptive transfer of Vegfr1-deficient monocytes. LysM-Cre can also be expressed by AEC2 (ref. 5) ; however, VEGFR1 expression in AEC2s was negligible compared to that in macrophages and monocytes in both control and injured lungs, such that the effects of LysM-Cre-mediated Vegfr1 deletion were probably due to effects on monocytes and/or macrophages, rather than on effects on AEC2s. Other Wnt ligands and macrophage-derived factors might also modulate PCEC function in lung repair, and future studies using cell type-specific knockouts will be needed to explore cross talk between perivascular macrophages and PCECs.
Macrophages are important in both the promotion and resolution of fibrosis during organ repair [41] [42] [43] [44] [45] [46] [47] [56] [57] [58] [59] . The pro-fibrotic VEGFR1 + perivascular macrophages that we have identified are reminiscent of a previously described pro-fibrotic monocyte and macrophage population 60 . The influence of the maladpated hematopoieticvascular niche, containing VEGFR1 + perivascular macrophages and PCECs, might be context and stage specific [50] [51] [52] [53] [54] . For example, it is conceivable that increased levels of the VEGFR1-specific ligand Plgf in chronically injured lungs specifically trigger the pathological function of VEGFR1 in macrophages, and future study is needed to identify both the cellular source of Plgf and the manner in which VEGFR1 is induced in the pro-fibrotic subset of macrophages. The contribution of dysfunctional epithelium in subverting the repair function of the hematopoietic-vascular niche should also be studied 1, 7, [9] [10] [11] .
Taken together, our results indicate that chronic lung injury recruits pro-fibrotic macrophages and suppresses a protective CXCR7 mechanism in PCECs, perpetuating the production of a pro-fibrotic endothelial signal-Jag1-that prohibits epithelial repair. Targeting of the hematopoietic-vascular niche 18 , which is readily accessible to the circulation, could enable regenerative therapy for lung disorders. Our findings might also help in the development of treatments for various fibrosis-related diseases that are major causes of death in developed countries 1, 9, 11 .
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
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ONLINE METHODS
Animals.
Cxcr7 loxP/loxP mice 23 , Jag1 loxP/loxP mice 61 , and mice harboring a floxed exon3 Ctnnb1 allele 48, 49, 62 were crossed with VE-cadherin-Cre ERT2 (Cdh5-PAC-Cre ERT2 ) transgenic mice 33 . These crosses generated VE-cadherin-Cre ERT2 Cxcr7 loxP/loxP , VE-cadherin-Cre ERT2 Jag1 loxP/loxP , and VE-cadherin-Cre ERT2 Ctnnb1-Ex3 loxP/+ mice. Four week-old male mice were then treated with tamoxifen at a dose of 200 mg/kg intraperitoneally (i.p.) once a day for 6 d and were allowed to rest for at least 10 d after the last injection, resulting in endothelial-specific deletion of Cxcr7, Jag1, and Cnnb1 gain of function in adult mice (Cxcr7 i∆EC/i∆EC , Jag1 i∆EC/i∆EC , Ctnnb1-ex3 i∆EC/+ ). Six-to ten-week-old male mice with endothelial cellspecific haplodeficiency of Jag1 or Cxcr7 (Jag1 i∆EC/+ or Cxcr7 i∆EC/+ ) were used as control groups for male Jag1 i∆EC/i∆EC and Cxcr7 i∆EC/i∆EC mice at the same age. Six-to eight-week-old male WT mice were used for mouse lung injury models and related treatments.
Six-to eight-week-old male transgenic Notch reporter (TNR) 63 mice were used to track Notch pathway activity in the injured lungs. TNR mice were also bred with VE-cadherin-Cre ERT2 Jag1 loxP/loxP to generate TNR + Jag1 i∆EC/i∆EC mice, which were injected with tamoxifen as described above, and six-to ten-week-old male mice were then examined for Notch pathway activity. Vegfr1-lacZ reporter mice and floxed Vegfr1 mice were generated by G.-H. Fong (University of Connecticut) 52 . LysM-Cre (Stock No. 004781) and β-catenin reporter Axin2-lacZ reporter (Stock No. 009120) mice were from the Jackson Labs. Six-to eight-week-old male Vegfr1-lacZ and Axin2-lacZ mice were used to measure Vegfr1 expression and β-catenin pathway activation, respectively, after bleomycin injection.
Investigators who performed mouse lung injury experiments and who analyzed the pattern and extent of cell activation and proliferation were randomly assigned with animals or samples from different experimental groups, and they were blinded to the genotype of the animals or samples. All animal experiments were carried out under the guidelines set by the Institutional Animal Care and Use Committee at Weill Cornell Medical College.
Mouse lung injury models. A repetitive i.t. bleomycin injection model was used to induce lung fibrosis 34 . Bleomycin sulfate powder (EMD) was suspended and dissolved in sterile PBS and injected i.t. into six-to eight-week-old male wild type mice or six-to ten-week-old male mice of the indicated genotypes at a dose of 1 unit/kg in a total volume of 50 µl PBS. During the injection process, mice were anesthetized with a cocktail of Ketamine and Xylazine. Mice were suspended vertically on a stand for orotracheal instillation, and 50 µl of bleomycin solution was administered through a 27-gauge angiocatheter. i.t. injection of hydrochloric acid (acid) was similarly performed as previously described 64 . Orotracheal instillation was performed in anesthetized mice, and 20 µl of an iso-osmolar solution of 0.1 M hydrochloric acid was instilled. After each injection of bleomycin or hydrochloric acid, mice were observed to ensure full recovery from anesthesia, and body temperature was maintained using an external heat source. After recovery, mice were transferred to ventilated cages with access to food and water. To examine the proliferation of type 2 alveolar epithelial cells (AEC2s) after bleomycin treatment, mice were euthanized 1 h after i.p. injection of 5-bromo-2′-deoxyuridine (BrdU). At the indicated time points after bleomycin or acid treatment, the oxygen tension in arterial blood of treated mice was measured as previously described using I-Stat (Abbott Laboratories, Abbott Park, IL) 36 .
Macrophage and monocyte depletion by clodronate liposome injection. We adopted a clodronate liposome administration method to selectively and effectively deplete macrophages and monocytes, including pulmonary macrophages 60 . The procedure and schedule of clodronate liposome injection was based on previously described kinetics of macrophage and monocyte depletion in both control and bleomycin-treated mice 60 .
To Macrophage and monocyte isolation and adoptive transfer. In order to interrogate the contribution of VEGFR1 + macrophages and monocytes during lung repair, six-to eight-week-old male wild type mice were injected with 50 µg of Plgf or equal amounts of CXCL12/SDF1, GM-CSF, and VEGFA (all from BioVision, Milpitas, CA) 1 d before the fourth injection of bleomycin or before PBS injection and every 3 d thereafter. Macrophages and monocytes were isolated from mouse lungs using the Monocyte Isolation Kit (Miltenyi Biotec) at day 10 after the fourth bleomycin injection or after PBS injection. The expression of cytokines and Wnt3A was examined by quantitative PCR. To examine the contribution of VEGFR1-expressing macrophages and monocytes in lung repair, monocytes were isolated from the bone marrow of mice with selective Vegfr1 deletion, using LysM-Cre (Vegfr1 ∆LysM/∆LysM ) or control (Vegfr1 +/+ ) mice. 3 × 10 6 Vegfr1 −/− monocytes (from Vegfr1 ∆LysM/∆LysM mice) or Vegfr1 +/+ monocytes were infused i.v. into macrophage-depleted control and Ctnnb1-Ex3 i∆EC mice after the fourth injection of bleomycin (the schedule is shown in Fig. 5a ). This adoptive transfer of monocytes was repeated after the fifth and sixth injections of bleomycin. Lung fibrotic responses were compared between control and Ctnnb1-Ex3 i∆EC mice receiving Vegfr1 +/+ and Vegfr1 −/− monocytes. To determine the effect of CXCR7 activation, 10 mg/kg TC14012 (R&D Systems) or vehicle was infused into the recipient mice through the trachea after monocyte transfer and repeated every 6 d. Jag1 and SMA protein levels in the lungs were detected by immunoblotting. Antibody information is described in Supplementary Table 1. Collagen deposition and morphology were tested by Sirius red and H&E staining.
Tissue harvesting and histology. For lung tissue collection, both lungs were thoroughly perfused with PBS via the pulmonary artery to remove residual blood in the vasculature. The right lung was removed from the thoracic cavity after the right hilum was tied. Lung lobes were separated, collected, and processed for subsequent experiments such as protein isolation and detection. The left lung was inflated from the identified and isolated trachea with a 21-gauge needle and syringe. The trachea was then tied under pressure. Each parameter from each individual animal was measured at least twice and averaged.
Fixed lungs were either embedded in paraffin or snap-frozen in OCT compound (Miles, Elkhart, IN). 10-µm-thick lung cryosections were made for immunofluorescence staining. Sirius red and H&E stainings were performed on paraffin-embedded lung sections to determine lung morphology and the distribution of collagen, using the Histoserv procedure (Germantown, MD).
Immunofluorescence, -galactosidase (LacZ) staining, and morphometric analysis. Lung frozen sections were blocked (5% donkey serum from Jackson ImmunoResearch (West Grove, PA, USA) (Cat. No. 017-000-121) & 0.3% Triton X-100) and incubated with primary antibodies (described in Supplementary Table 1) at 4 °C overnight 15 . Lung sections six-to eight-week-old male TNR mice, in which GFP fluorescence indicates Notch activation, were co-stained with the PCEC marker VE-cadherin and the fibroblast antigen desmin. After the sections were washed with PBS and incubated with fluorescent dyeconjugated secondary antibodies (Jackson ImmunoResearch, West Grove, PA), nuclear staining was carried out with DAPI using Prolong Gold mounting medium (Invitrogen). Cell proliferation (BrdU incorporation) was measured by immunostaining for BrdU (Sigma). BrdU incorporation in the lungs was detected as described in ref. 15 . Fluorescence images were captured on an AxioVert LSM710 microscope (Zeiss). To determine the fluorescence signal in tissue sections, fluorescent cells in five different high-power fields from each slide were quantified. Image analysis was performed in a blinded fashion. Investigators were not aware of the genotype of animals or the identity of samples during scoring.
β-galactosidase (LacZ) activity in mouse lungs was determined from the cyropreserved lung slides after fixation with 0.1% glutaraldehyde as previously described 52 . Six-to eight-week-old male Vegfr1-lacZ and Axin2-lacZ mice were used. Alveolar morphology was independently assessed by two investigators using five randomly selected fields in each H&E slide.
Lung fibrosis determination. Right top lung lobes were homogenized in tissue lysis buffer. Immunoblotting for SMA and collagen I was performed using npg the lung tissue lysates. PFA-fixed lung sections were stained with Sirius red to assess collagen deposition and distribution, following the Histoserv protocol (Germantown, MD). Lung fibrotic parenchyma was assessed using five random fields in each section and quantified as previously described 23 .
Hydroxyproline content was quantified in the lungs to determine the extent of fibrosis 10, 65 . Right lower lobes were weighed, homogenized, and baked in 12 N hydrochloric acid overnight at 120 °C. Next, the samples were aliquotted and added to 1.4% chloramine T in 0.5 M sodium acetate/10% isopropanol (Sigma). After incubation for 20 min at room temperature, the samples were incubated with Erlich's solution at 65 °C for 15 min. Absorbance at the wavelength of 540 nm was determined, and the content of hydroxyproline was calculated by comparing the absorbance to a hydroxyproline standard curve. Hydroxyproline content in the lung was determined on the basis of the weight of the right lower lung lobe and that of the total lung.
Cells. Mouse PCECs and lung fibroblasts were isolated from lungs by flow sorting or sheep anti-rat Dynabeads (Invitrogen) as previously described 15, 66 . PCECs and lung fibroblasts were identified by rat anti-mouse CD31 (clone Mec13.3) and VE-cadherin (clone Bv13) antibodies (for PCECs) and anti-mouse PDGFRβ clone APB5 antibody (for fibroblasts). For Dynabead-based isolation, Dynabeads were prepared 1 d before isolation. Beads were washed three times and suspended in 200 µl PBS containing 0.1% bovine serum albumin (BSA), 2 mM EDTA, and 1% penicillin/streptomycin/Fungizone (P/S/F). 2.5 µg of each type of rat antibody was added to 10 µl of beads and rotated for 1 h at room temperature and then 4 °C overnight. Beads were washed three times and suspended in the original buffer with same volume.
For lung digestion, we used a digestion cocktail solution containing 2 mg/ml collagenase A and 1 mg/ml Dispase (Roche Life Science) in Hank's Balanced Salted Solution (HBSS). 1 ml digestion solution was directly instilled via the trachea and used to perfuse via pulmonary artery to accelerate the digestion process. Perfused mouse lung tissues were then removed from the chest cavity to RPMI1640 medium (Gibco), after which they were gently minced and disrupted by passing through an 18-G syringe. Lung tissues were then suspended in digestion cocktail (100 mg in 2.5 ml) for 15 min at 37 °C. Digested tissue was filtered through a sterile 40-µm nylon mesh (cell strainer), centrifuged, and suspended in the original volume. After filtration, released lung cells were incubated with 1 µg/ml fluorescently labeled rat-anti mouse VE-cadherinand CD31-specific antibodies for flow sorting or 10 µl of conjugated beads for Dynabead isolation. After the supernatant was carefully aspirated and washed 5 times in PBS + 0.1% BSA + 2 mM EDTA + 1% P/S/F, fluorescent antibody-stained or bead-bound cells were collected using a flow sorter or magnet. Isolated PCECs or fibroblasts were directly subjected to subsequent analyses, unless specified as cultivated cells.
Cell cultivation and shRNA transduction. Cultivation of mouse PCECs was performed on 25 µg/ml fibronectin-coated plates as previously described 67 . Isolated mouse PCECs were transduced with the E4ORF1 gene and with a gene encoding hyperactive c-Raf to maintain endothelial cell survival in serum-free conditions 67 . Five shRNA clones (TRCN0000028933, TRCN0000028887, TRCN0000028869, TRCN0000028860 and TRCN0000028850) were obtained from Open Biosystems and used to perform gene knockdown of Jag1 in cultivated PCECs. Clone TRCN0000028887 (referred to as clone 2) showed the highest efficiency in silencing Jag1 in cultivated PCECs. A negative control vector was constructed using a scrambled (Srb) sequence designed by GeneCopoeia that does not match any genomic sequence (Cat. No. CSHCTR001). Lentiviral particles were generated by co-transfecting 15 µg of shuttle lentiviral vector containing Jag1 shRNA or Srb sequence, 3 µg of pENV/VSV-G, 5 µg of pRRE, and 2.5 µg of pRSV-REV in 293T cells by the Fugene (Roche) method. Viral supernatants were concentrated by Lenti-X concentrator (Clontech, Cat. No. 631232). After titration with Lenti-X p24 rapid titer kit (Clontech, Cat. No. 632200), 25,000 pg of virus was used to transduce 1,000,000 PCECs.
Human pulmonary fibrosis samples. Human pulmonary fibrosis and normal tissues were purchased from Origene (Rockville, MD). The characteristics of the pulmonary fibrosis samples were as follows: Patient 1 (Cat. No. CS502727): H&E staining shows 45% alveoli, 0% bronchioles, 30% fibrovascular tissue, 25% diffuse interstitial fibrosis. Patient 2 (Cat. No. CS504978): H&E staining shows 65% alveoli, 10% bronchioles, 25% fibrovascular septae; contains interstitial fibrosis and chronic inflammation. Patient 3 (Cat. No. CS504492): H&E staining shows 65% alveoli, 15% bronchioles, 20% fibrovascular septae, and interstitial fibrosis. Two individual normal lung tissues exhibiting regular alveolar architecture and morphology by H&E staining were similarly analyzed and compared with patient samples.
In vivo modulation of gene expression in PCECs by pseudotyped lentiviral particles. To couple lentiviral particles with an antibody recognizing endothelial surface antigen, we adopted a packaging system to generate pseudotyped lentivirus 37 . Viral particles were produced by transfection of 293T cells with lentiviral constructs of Jag1 shRNA, scrambled sequence (Srb), or GFP and packaging vector pMDL/pPRE, and pRSV-REV, as well as pseudotyped vector 2.2 that replaced pVSV-G 37 . Inclusion of pseudotyped vector 2.2 in the packaging system enables the generation of lentiviral particles bearing an immunoglobulin G (IgG) binding motif on the particle surface. Lentiviral particles were concentrated using the Lenti-X concentrator kit (Clontech). Virus titer was normalized to lentiviral core/capsid protein p24 using the Lenti-X p24 Rapid Titer Kit (Clontech). For conjugation of Mec13.3-specific antibody (BD Biosciences) with lentiviral particles, concentrated virus was suspended in PBS at a concentration of 30 µg/ml p24 capsid protein and incubated with a twofold excess of Mec13.3 antibody or rat IgG (Jackson ImmunoResearch, Cat. No. 012-000-002). Conjugated lentiviral particles were purified again and resuspended in sterile PBS.
To test the efficiency of virus delivery, two groups of six-to eight-week-old male WT mice were injected i.v. with GFP-expressing lentivirus conjugated to Mec13.3 or rat IgG, with the titer normalized to 10 µg of p24 capsid protein. GFP expression in VE-cadherin + PCECs and E-cadherin + AECs was determined by co-staining of GFP with antibodies specific to VE-cadherin and E-cadherin (BD Biosciences).
Effects of CXCR7 agonist and endothelial cell-specific delivery of Jag1 shRNA on lung fibrosis. Pseudotyped lentiviral particles containing shJag1 were conjugated with the anti-mouse CD31 antibody Mec13.3 to induce shJag1 expression in endothelial cells (shJag1 EC ). Five different viruses, each containing a different mouse Jag1 shRNA clone, were conjugated with the anti-CD31 mAb Mec13.3 separately, resulting in five types of shJag1 EC viruses (shJag1 EC C1-C5). Lentiviral particles containing the Srb construct were similarly processed with Mec13.3 as a control group (Srb EC ). After the fourth bleomycin injection, six-to ten-week-old week old male WT mice were subjected to Mec13.3-conjugated shJag1 EC or Srb EC every 6 d at a dose of 10 µg of p24 capsid protein. To test the ability of each Mec13.3-coupled virus to attenuate Notch activation in the lungs of bleomycin-injected mice, lung fibroblasts were isolated as described above at day 35 after the sixth bleomycin injection, and Hes1 protein expression in the isolated mouse lung fibroblasts was analyzed by immunoblotting with a Hes1-specific antibody (Abcam, Cat. No. ab71559). Knockdown of Jag1 in PCECs after injection of shJag1 EC was tested by immunostaining and immunoblotting. Because Jag1 shRNA clone 2 conjugated to Mec13.3 exhibited the highest efficiency in abrogating Hes1 activation in mouse lung fibroblasts after repeated bleomycin injection, results obtained using clone 2-containing virus are presented throughout, unless otherwise specified. shJag1 EC and Srb EC were similarly administered to six-to eight-week-old male WT mice after the second administration of acid with the same dose and schedule. Six-to ten-weekold male Cxcr7 i∆EC/i∆EC and randomly distributed male and female Cxcr7 +/+ mice were also treated with shJag1 EC , Srb EC , Mec13.3, or rat IgG with the same injection dose and schedule as above.
The CXCR7-selective agonist TC14012 or vehicle (saline) were i.t. administered into mice at 10 mg/kg immediately after the third injection of bleomycin or the second administration of acid and every 4 d thereafter. After TC14012 or shJag1 EC virus injection, alveolar epithelial structure was examined by co-staining for aquaporin-5 (Abcam, Cat. No. ab78486) and podoplanin (R&D, Cat. No. AF3244). Lung fibrotic responses were determined at the indicated time points after bleomycin or acid administration, including immunoblot analysis of SMA and collagen I, Sirius red staining, and determination of lung hydroxyproline content. 
